SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-018539
Filing Date
2020-03-12
Accepted
2020-03-12 16:40:57
Documents
1
Period of Report
2020-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6592
  Complete submission text file 0001209191-20-018539.txt   8302
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 NORTH LAURA STREET SUITE 2500 JACKSONVILLE FL 32202
Business Address 904-257-8704
Loiacono Michael (Reporting) CIK: 0001679119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 20709363